← Back to news
Y

Yahoo Finance

US cranks up pressure on China EVs with Polestar ban

Y

Supermicro Stock Jumps on Wall Street Upgrade. The Real Test Is Still Ahead.

Y

4 Stocks Powering the AI Revolution Behind the Scenes

Y

Seller concessions vs. seller credit: What's the difference?

Y

Bitcoin and ethereum prices today, Thursday, June 25, 2026: Bitcoin tumbles further below $60,000

Y

Bitcoin and ethereum prices today, Thursday, June 25, 2026: Bitcoin hits its lowest levels in years

Y

Apple raises prices of MacBooks, iPads as memory costs skyrocket

Y

SpaceX (SPCX) Is Down 31% From Its High and Is Now Borrowing $25 Billion. Should Investors Be Worried?

Y

PCE Inflation Data, Falling Oil Prices Calm Fed Fears (Live Coverage)

Y

World stocks climb on chip rally; dollar steadies near one-year high

Y

5 High-Yielding Dividend Kings Retirees and Boomers Can Buy Today and Safely Hold Forever

Y

Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth

Y

Is Lands’ End, Inc. (LE) Stock Set for Growth After Debt Reduction and Strategic Partnership?

Y

Can Palladyne AI Corp. (PDYN) Benefit From Rising Demand for Advanced Defense Technologies?

Y

Is Perion Network Ltd. (PERI) Positioning Itself as an AI-Powered AdTech Growth Story?

Y

Is Bed Bath & Beyond, Inc. (BBBY) Rebuilding Customer Engagement Through Its Legendary Coupon Hunt?

Y

Is Yext, Inc. (YEXT) Facing Growth Challenges After Mixed Q1 Results and Analyst Downgrade?

Y

Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform

Y

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

Y

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?

Y

Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches?

Y

Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler

Y

PCE report: Fed's preferred inflation measure hits 3-year high, keeping talk of possible rate hike in play

Y

Fed's preferred inflation measure hits three-year high, keeping talk of possible rate hike in play

Y

Fed's preferred inflation measure hits 3-year high, keeping talk of possible rate hike in play

Y

Is Haleon plc (HLN) Stock Still a Growth Opportunity After Analyst Downgrade?

Y

Key inflation gauge jumps to 3-year high in latest sign of affordability challenges

Y

Is GE HealthCare Technologies Inc. (GEHC) Expanding Its Healthcare Technology Lead Through AI-Powered Imaging Solutions?

Y

May US PCE inflation tops 4%, leaves Fed hike on the table

Y

Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data?

Y

UniQure N.V. (QURE) Upgraded to Overweight as Huntington’s Disease Program Advances

Y

Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data

Y

Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues?

Y

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Y

Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?

Y

AI-Native Wealth Manager Arca Raises $64M

Y

JPMorgan loses a key figure in the race to succeed CEO Jamie Dimon

Y

HIVE Digital Technologies inks LOI for 10-year lease at Sweden data center, plans $100M exchangeable notes offering

Y

Analysts Expect Another Stellar Year For This Specialty Chipmaker

Y

JPMorgan Shakes Up Succession Race for Jamie Dimon With Two New Presidents

Y

Consumer confidence hit a historic low — but stock markets are rallying. Here's why the data may be wrong

Y

UK car production up in May

Y

Should You Really Buy Tech Stocks Now? History Offers a Surprising Answer That's Strikingly Clear.

Y

Wheat Showing Slight Losses Early on Thursday

Y

Soybeans Holding onto Gains Early on Thursday

Y

Corn Showing Fractionally Mixed Trade on Thursday Morning

Y

Gold falls below $4,000 on Fed rate hike bets under Kevin Warsh

Y

3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree

Y

Daily – Vickers Top Buyers & Sellers for 06/25/2026

Y